A new Fierce Biotech article features insights from Paul Evans on what to expect for clinical research in 2025. Topics include rising costs and uncertain regulations, as well as the continued emergence of site networks, AI-driven efficiency (with technology built “by trial sites, for trial sites”), and enhanced diversity initiatives.
Read the article here: https://www.fiercebiotech.com/cro/clinical-trials-industry-set-uncertain-interconnected-2025-according-velocity-clinical-research
